<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; ALLI</title>
	<atom:link href="http://www.stockbloghub.com/tag/alli/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Sun, 20 May 2012 20:27:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(ALLI) Allion Healthcare Beats Estimates by a Penny</title>
		<link>http://www.stockbloghub.com/2009/12/04/alli-allion-healthcare-beats-estimates-by-a-penny/22054</link>
		<comments>http://www.stockbloghub.com/2009/12/04/alli-allion-healthcare-beats-estimates-by-a-penny/22054#comments</comments>
		<pubDate>Sat, 05 Dec 2009 01:26:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ALLI]]></category>
		<category><![CDATA[Allion Healthcare]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22054</guid>
		<description><![CDATA[Allion Healthcare (ALLI) reported third quarter earnings of 13 cents per share excluding expenses related to the merger with an affiliate of H.I.G. Capital, LLC, beating the Zacks Consensus Estimate by a penny. The company reported identical earnings in the year-ago quarter. Revenues for the quarter came in at $103.4 million as against $92.1 million in the year-ago period, up 12.2%. Segment-wise, the specialty HIV division, through which Allion provides specialty pharmacy and disease management services focused on HIV/AIDS patients, recorded revenues of $78.4 million opposed to $ 70.3 million in the third quarter of 2008, up 11.5%. The increase in revenues in this segment is primarily attributable to an 8.2% increase in prescription volume and, to a lesser extent, an increase in the price of the anti-retroviral drugs sold ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/04/alli-allion-healthcare-beats-estimates-by-a-penny/22054/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ALLI) Allion Healthcare to be Acquired by H.I.G. Capital</title>
		<link>http://www.stockbloghub.com/2009/10/19/alli-allion-healthcare-to-be-acquired-by-h-i-g-capital/18109</link>
		<comments>http://www.stockbloghub.com/2009/10/19/alli-allion-healthcare-to-be-acquired-by-h-i-g-capital/18109#comments</comments>
		<pubDate>Mon, 19 Oct 2009 16:42:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ALLI]]></category>
		<category><![CDATA[Allion Healthcare]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18109</guid>
		<description><![CDATA[Recently, Allion Healthcare Inc. (ALLI) inked a deal with an affiliate of H.I.G. Capital, LLC, a leading global private investment firm, whereby it agreed to be acquired by the private company. The deal is worth approximately $278 million. The amount is inclusive of the assumption or repayment of about $79 million of indebtedness. The transaction is expected to close in the first quarter of 2010. Under the terms of the transaction, Allion shareholders would receive $6.60 per share in cash. This represents a premium of 30.2% over Allion&#8217;s five-day average closing price before the announcement of the deal. Consequently, this transaction provides substantial financial gains to Allion shareholders. The transaction has been approved by Allion’s Board of Directors. Additionally, other shareholders of Allion Incorporatedluding Parallex LLC, who in aggregate hold ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/19/alli-allion-healthcare-to-be-acquired-by-h-i-g-capital/18109/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ALLI) Allion Healthcare Inc. &#8211; Aggressive Growth &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/04/22/alli-allion-healthcare-inc-aggressive-growth-zacks-rank-buy/5882</link>
		<comments>http://www.stockbloghub.com/2009/04/22/alli-allion-healthcare-inc-aggressive-growth-zacks-rank-buy/5882#comments</comments>
		<pubDate>Wed, 22 Apr 2009 22:37:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[ALLI]]></category>
		<category><![CDATA[Allion Healthcare Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=5882</guid>
		<description><![CDATA[Allion Healthcare, Inc. (ALLI) has been growing steadily since its acquisition of Biomed was finalized one year ago. Company Description Allion Healthcare, Inc. is a national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients. Allion Healthcare sells HIV/AIDS medications, ancillary drugs and nutritional supplies under the trade name MOMS Pharmacy. Sales Up 52% On Mar 4 Allion announced fourth-quarter results that included sales of $96.9 million, up 52% from $63.6 million. Strong sales drove net income up to $3.1 million, almost triple last year&#8217;s $1.1 million. Earnings per share doubled to 12 cents, which met analysts&#8217; expectations. Before meeting the consensus Allion beat the Street 3 consecutive quarters. Successful Acquisition Much of the recent success of the company has been due to the acquisition of Biomed, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/04/22/alli-allion-healthcare-inc-aggressive-growth-zacks-rank-buy/5882/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

